| Old Articles: <Older 7171-7180 Newer> |
|---|
 |
The Motley Fool
February 15, 2011
Rich Smith |
What's Behind the Run-Up at Exelixis? One word: earnings. Shares of this tiny drug developer have taken off like a rocket.   |
Pharmaceutical Executive
February 1, 2011
Jennifer Ringler |
Skipping the Needle: Pharm Exec's Brand of the Year Novartis' Gilenya is a step forward in treating Multiple Sclerosis. But generating increased compliance is another story |
Pharmaceutical Executive
February 1, 2011
Jon Zifferblat |
China: Business as UNusual If there is one market that requires a click on the 'refresh' button, it's China. General Biologic provides a snapshot of what's ahead for Big Pharma in the country |
Pharmaceutical Executive
February 1, 2011
William Looney |
To Align an Audience, Find a Pulse All this uncertainty at the back end of drug development is a drain on future therapeutic progress against disease. It's a job killer, too. |
Pharmaceutical Executive
February 1, 2011
Frederic Brunner |
Growing Stronger After the Storm To manage through a resource-constrained environment, it is essential to get the most out of procurement planning |
Pharmaceutical Executive
February 1, 2011
William Looney |
Tracking the US Market: A Statistical Self-Portrait What are some of the essential characteristics of the US market? Statistics drawn from the 2011 Statistical Abstract of the US shed some light |
The Motley Fool
February 15, 2011
Brian Orelli |
Obama Hates Your Drugmaker The president's proposal in favor of earlier generics would mean lower profits for some companies. |
The Motley Fool
February 14, 2011
Brian Orelli |
This Biotech Is Heating Up Biosante Pharmaceuticals was up more than 9% at one point today after the company said the independent Data Monitoring Committee believed Biosante's female sexual dysfunction drug, LibiGel, was safe enough to allow the trial to continue. |
The Motley Fool
February 14, 2011
Matt Koppenheffer |
Emergency Medical Services Shares Plunged: What You Need to Know Shares of emergency medical services provider -- and aptly named company -- Emergency Medical Services were experiencing trauma today as shares fell 11% on heavy trading volume. |
The Motley Fool
February 12, 2011
Dan Dzombak |
Agilent's Management Is Creating Value What economic value added momentum shows us about the folks running Agilent. |
| <Older 7171-7180 Newer> Return to current articles. |
